{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T14:47:45Z","timestamp":1766760465467},"reference-count":23,"publisher":"The Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9,1]]},"DOI":"10.1210\/jc.2014-2017","type":"journal-article","created":{"date-parts":[[2014,7,16]],"date-time":"2014-07-16T14:27:21Z","timestamp":1405520841000},"page":"3103-3111","source":"Crossref","is-referenced-by-count":26,"title":["Effect of Paricalcitol on Circulating Parathyroid Hormone in X-Linked Hypophosphatemia: A Randomized, Double-Blind, Placebo-Controlled Study"],"prefix":"10.1210","volume":"99","author":[{"given":"Thomas O.","family":"Carpenter","sequence":"first","affiliation":[{"name":"Departments of Pediatrics (Endocrinology) (T.O.C., E.A.O., B.K.E.), New Haven, Connecticut 06520"},{"name":"Orthopaedics and Rehabilitation (T.O.C., C.M.G.), New Haven, Connecticut 06520"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Olear","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics (Endocrinology) (T.O.C., E.A.O., B.K.E.), New Haven, Connecticut 06520"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane H.","family":"Zhang","sequence":"additional","affiliation":[{"name":"the Veterans Administration Cooperative Studies Program Coordinating Center (JHZ), Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut 06516"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce K.","family":"Ellis","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics (Endocrinology) (T.O.C., E.A.O., B.K.E.), New Haven, Connecticut 06520"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine A.","family":"Simpson","sequence":"additional","affiliation":[{"name":"Internal Medicine (Endocrinology) (C.A.S., K.L.I.), New Haven, Connecticut 06520"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Cheng","sequence":"additional","affiliation":[{"name":"Diagnostic Radiology (Nuclear Medicine) (D.C.), Yale University School of Medicine, New Haven, Connecticut 06520"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caren M.","family":"Gundberg","sequence":"additional","affiliation":[{"name":"Orthopaedics and Rehabilitation (T.O.C., C.M.G.), New Haven, Connecticut 06520"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl L.","family":"Insogna","sequence":"additional","affiliation":[{"name":"Internal Medicine (Endocrinology) (C.A.S., K.L.I.), New Haven, Connecticut 06520"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113473364900_B1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0002-9343(64)90085-3","article-title":"Vitamin D-resistant rickets","volume":"36","author":"Burnett","year":"1964","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2019041113473364900_B2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/B978-0-12-382040-2.10026-7","article-title":"Familial hypophosphatemia and related disorders","volume-title":"Pediatric Bone: Biology, Diseases","author":"Holm","year":"2012","edition":"2nd ed"},{"key":"key\n\t\t\t\t2019041113473364900_B3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1210\/jcem-58-4-671","article-title":"Effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on tubular handling of phosphate in hypophosphatemic rickets","volume":"58","author":"Alon","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113473364900_B4","first-page":"1378","article-title":"Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia","volume":"78","author":"Carpenter","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113473364900_B5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0002-9343(85)90411-5","article-title":"Development of hypercalcemic hyperparathyroidism after long-term phosphate supplementation in hypophosphatemic osteomalacia. Report of two cases","volume":"78","author":"Firth","year":"1985","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2019041113473364900_B6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2265.1995.tb01863.x","article-title":"Autonomous hyperparathyroidism in X-linked hypophosphataemia","volume":"42","author":"Knudtzon","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113473364900_B7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.bone.2012.05.015","article-title":"FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1\/2-SGK1 signaling pathway","volume":"51","author":"Andrukhova","year":"2012","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041113473364900_B8","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1210\/jcem-60-4-711","article-title":"The concurrence of hypoparathyroidism provides new insights to the pathophysiology of X-linked hypophosphatemic rickets","volume":"60","author":"Lyles","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113473364900_B9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/MNH.0b013e328303e172","article-title":"Fibroblast growth factor 23 acts on the parathyroid to decrease parathyroid hormone secretion","volume":"17","author":"Galitzer","year":"2008","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"key\n\t\t\t\t2019041113473364900_B10","doi-asserted-by":"crossref","first-page":"E352","DOI":"10.1210\/jc.2010-0589","article-title":"Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment and relationship to parathyroid status","volume":"95","author":"Carpenter","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113473364900_B11","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0022-3476(05)82149-3","article-title":"Acute effects of calcitriol and phosphate salts on mineral metabolism in children with hypophosphatemic rickets","volume":"118","author":"Bettinelli","year":"1991","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t2019041113473364900_B12","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1053\/ajkd.1998.v32.pm9808145","article-title":"Therapy of secondary hyperparathyroidism with 19-nor-1\u03b1,25-dihydroxyvitamin D2","volume":"32","author":"Martin","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t2019041113473364900_B13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2165\/00003495-200565040-00008","article-title":"Paricalcitol: a review of its use in the management of secondary hyperparathyroidism","volume":"65","author":"Robinson","year":"2005","journal-title":"Drugs"},{"key":"key\n\t\t\t\t2019041113473364900_B14","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia","volume":"24","author":"Jonsson","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113473364900_B15","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1359\/jbmr.090509","article-title":"Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets\/osteomalacia","volume":"24","author":"Aono","year":"2009","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113473364900_B16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev.med.051308.111339","article-title":"Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23","volume":"61","author":"Bergwitz","year":"2010","journal-title":"Annu Rev Med"},{"key":"key\n\t\t\t\t2019041113473364900_B17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nrneph.2010.17","article-title":"Recent advances in renal phosphate handling","volume":"6","author":"Farrow","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"key\n\t\t\t\t2019041113473364900_B18","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1210\/en.2007-0243","article-title":"Early lethality in Hyp mice with targeted deletion of Pth gene","volume":"148","author":"Bai","year":"2007","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041113473364900_B19","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2215\/CJN.04981107","article-title":"Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets","volume":"3","author":"Alon","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019041113473364900_B20","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1530\/EJE-08-0383","article-title":"A case of X-linked hypophosphatemic rickets: complications and the therapeutic use of cinacalcet","volume":"159","author":"Raeder","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113473364900_B21","doi-asserted-by":"crossref","first-page":"274","DOI":"10.14310\/horm.2002.1277","article-title":"Cinacalcet in hyperparathyroidism secondary to X-linked hypophosphatemic rickets: case report and brief literature review","volume":"9","author":"Yavropoulou","year":"2010","journal-title":"Hormones"},{"key":"key\n\t\t\t\t2019041113473364900_B22","unstructured":"US Food and Drug Administration. Sensipar (cinacalcet hydrochloride): Drug Safety Communication. FDA suspends pediatric clinical trials after report of death. http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/ucm341255.htm Published February 26, 2013. July 19, 2014."},{"key":"key\n\t\t\t\t2019041113473364900_B23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00008480-200108000-00015","article-title":"Ectopic cardiac calcification associated with hyperparathyroidism in a boy with hypophosphatemic rickets","volume":"13","author":"Moltz","year":"2001","journal-title":"Curr Opin Pediatr"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/9\/3103\/9049002\/jcem3103.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T22:05:40Z","timestamp":1565647540000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/99\/9\/3103\/2537866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,1]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2014-2017","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,1]]}}}